Cargando…
Effects of aspirin on the long-term management of depression in older people: A double blind randomized placebo-controlled trial.
Late-life depression is common and often inadequately managed using existing therapies. Depression is also associated with increased markers of inflammation, suggesting a potential role for anti-inflammatory agents. ASPREE-D is a sub-study of ASPREE, a large multi-centre, population-based, double-bl...
Autores principales: | Berk, Michael., Agustini, Bruno., Woods, Robyn. L., Nelson, Mark. R., Shah, Raj. C., Reid, Christopher. M., Storey, Elsdon., Fitzgerald, Sharyn. M., Lockery, Jessica. E, Wolfe, Rory., Mohebbi, Mohammadreza., Dodd, Seetal., Murray, Anne. M., Stocks, Nigel., Fitzgerald, Paul. B., Mazza, Catherine., McNeil, John. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8313623/ https://www.ncbi.nlm.nih.gov/pubmed/33504953 http://dx.doi.org/10.1038/s41380-021-01020-5 |
Ejemplares similares
-
Age-related macular degeneration in a randomized controlled trial of low-dose aspirin: Rationale and study design of the ASPREE-AMD study
por: Robman, Liubov, et al.
Publicado: (2017) -
Sleep‐disordered breathing was associated with lower health‐related quality of life and cognitive function in a cross‐sectional study of older adults
por: Ward, Stephanie A., et al.
Publicado: (2022) -
Low-Dose Aspirin and the Risk of Stroke and Intracerebral Bleeding in Healthy Older People: Secondary Analysis of a Randomized Clinical Trial
por: Cloud, Geoffrey C., et al.
Publicado: (2023) -
AspiriN To Inhibit SEPSIS (ANTISEPSIS) randomised controlled trial protocol
por: Eisen, Damon P, et al.
Publicado: (2017) -
ASPIRIN BENEFIT IS NOT AFFECTED BY BODY WEIGHT IN HEALTHY OLDER PERSONS
por: Woods, Robyn L, et al.
Publicado: (2019)